References
- GOLDGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2015 Available from: http://www.goldcopd.com/Accessed March 10, 2015
- GudmundssonGGislasonTJansonCDepression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countriesRespir Med20061001879315893921
- HananiaNAMullerovaHLocantoreNWDeterminants of depression in the ECLIPSE chronic obstructive pulmonary disease cohortAm J Respir Crit Care Med2011183560461120889909
- UrffMvan den BergJWUilSMChavannesNHDamoiseauxRADepression and heart failure associated with clinical COPD questionnaire outcome in primary care COPD patients: a cross-sectional studyNPJ Prim Care Respir Med2014241406625230736
- CazzolaMMacNeeWMartinezFJOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J200831241646918238951
- BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
- Garcia-AymerichJGomezFPBenetMIdentification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax201166543043721177668
- GSKANORO™ ELLIPTA® prescribing information2014 Available from: https://www.gsksource.com/gskprm/htdocs/documents/ANORO-ELLIPTA-PI-MG.PDFAccessed June 1, 2015
- GSKANORO™ ELLIPTA® summary of product characteristics2014 Available from: http://www.medicines.org.uk/emc/medicine/28949#INDICATIONSAccessed June 1, 2015
- DonohueJFMaleki-YazdiMRKilbrideSMehtaRKalbergCChurchAEfficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPDRespir Med2013107101538154623830094
- World Medical AssociationWorld Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects2008 Available from: http://www.wma.net/en/30publications/10policies/b3/17c.pdfAccessed June 1, 2015
- CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
- JonesPWSt George’s Respiratory Questionnaire: MCIDCOPD200521757917136966
- DonohueJFMinimal clinically important differences in COPD lung functionCOPD20052111112417136971
- SinghDFergusonGTBolitschekJTiotropium + olodaterol shows clinically meaningful improvements in quality of lifeRespir Med2015109101312131926320402
- VogelmeierCKardosPHarariSGansSJStengleinSThirlwellJFormoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month studyRespir Med2008102111511152018804362
- BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J20134261484149423722616
- IsmailaASHuismanELPunekarYSKarabisAComparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysisInt J Chron Obstruct Pulmon Dis2015102495251726604738
- CopeSDonohueJFJansenJPComparative efficacy of long-acting bronchodilators for COPD: a network meta-analysisRespir Res20131410024093477